ARCTOS NORTHSTAR ACQUISIT-A (ANAC)

Arctos NorthStar Acquisition Corp. Announces Redemption of Class A Ordinary Shares

Stemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Arctos NorthStar Acquisition Corp. Announces Receipt of NYSE Continued Listing Standard Notice

Arctos NorthStar Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing April 15, 2021

Arctos NorthStar Acquisition Corp. Announces Pricing of $275 Million Initial Public Offering

Immune Pharmaceuticals: Two For The Price Of One

Immune Pharmaceuticals is gearing up for its split into two pure play companies with new patent filings, strategic deals for commercialization, and the initiation of new clinical trials to support its wide-ranging pipeline.